A study by a Massachusetts General Hospital (MGH) research team finds that neurogenesis – inducing the production of new neurons – in the brain structure in which memories are encoded can improve cognitive function in a mouse model of Alzheimer’s disease. Their investigation shows that those beneficial effects on cognition can be blocked by the hostile inflammatory environment present in the brain of patients with Alzheimer’s disease and that physical exercise can “clean up” the environment, allowing new nerve cells to survive and thrive and improving cognition in the Alzheimer’s mice.
“In our study we showed that exercise is one of the best ways to turn on neurogenesis and then, by figuring out the molecular and genetic events involved, we determined how to mimic the beneficial effects of exercise through gene therapy and pharmacological agents,” says Rudolph Tanzi, PhD, director of the Genetics and Aging Research Unit, vice-chair of the Department of Neurology and co-director of the Henry and Alison McCance Center for Brain Health at MGH and senior author of the paper published in Science.
Lead author, Se Hoon Choi, Ph.D., of the Genetics and Aging Research Unit adds, “While we do not yet have the means for safely achieving the same effects in patients, we determined the precise protein and gene targets for developing ways to do so in the future.”
Adult neurogenesis – production of new neurons occurring after the embryonic and, in some animals, neonatal periods – takes place in the hippocampus and another brain structure called the striatum. While adult hippocampal neurogenesis is essential to learning and memory, how the process impacts neurodegenerative conditions like Alzheimer’s disease has not been well understood. The MGH team set out to investigate how impairment of adult hippocampal neurogenesis (AHN) contributed to Alzheimer’s disease pathology and cognitive function in a mouse model and whether increasing AHN could reduce symptoms.
Their experiments showed that AHN could be induced in the model either by exercise or by treatment with drugs and gene therapy that promoted the birth of neural progenitor cells. Behavioral testing of animals revealed limited cognitive benefits for animals in which neurogenesis had been induced pharmacologically and genetically. But animals in which AHN was induced by exercise showed improved cognitive performance and reduced levels of beta-amyloid.
“Although exercise-induced AHN improved cognition in Alzheimer’s mice by turning on neurogenesis, trying to achieve that result by using gene therapy and drugs did not help,” Tanzi explains. “That was because newly born neurons, induced by drugs and gene therapy, were not able to survive in brain regions already ravaged by Alzheimer’s pathology, particularly neuroinflammation. So we asked how neurogenesis induced by exercise differs.”
Choi says, “We found the key difference was that exercise also turned on the production of brain-derived neurotrophic factor or BDNF – known to be important for the growth and survival of neurons – which created a more hospitable brain environment for the new neurons to survive. By combining drugs and gene therapy that both induced neurogenesis and increased BDNF production, we were able to successfully mimic the effects of exercise on cognitive function” Choi is an assistant professor of Neurology at Harvard Medical School (HMS).
Tanzi adds,“The lesson learned was that it is not enough just to turn on the birth of new nerve cells, you must simultaneously ‘clean up’ the neighborhood in which they are being born to make sure the new cells survive and thrive. Exercise can achieve that, but we found ways of mimicking those beneficial cognitive effects by the application of drugs and gene therapy that simultaneously turn on neurogenesis and BDNF production.”
In another part of the study, the investigators found that blocking neurogenesis in young Alzheimer’s mice shortly after birth led to more pronounced cognitive deficits later in life. “We will next explore whether safely promoting neurogenesis in Alzheimer’s patients will help alleviate the symptoms of the disease and whether doing so in currently healthy individuals earlier in life can help prevent symptoms later on,” says Tanzi, the Joseph P. and Rose F. Kennedy Professor of Neurology at HMS. “We are very excited to now investigate ways of implementing our new findings to more effectively treat and prevent this terrible disease.”
Additional co-authors of the Science paper are Enjana Bylykbashi, Zena Chatila, Eunhee Kim, Alexander Rompala, Mary Oram, Caroline Asselin, Jenna Aronson, Can Zhang, PhD, Sean Miller, Andrea Lesinski, and Doo Yeon Kim, PhD, Genetics and Aging Research Unit, MGH Neurology; Benjamin Pulli, MD, and John W. Chen, MD, PhD, MGH Radiology; Star W. Lee, PhD, Gregory Clemenson, PhD, and Fred H. Gage, MS, PhD, Salk Institute for Biological Studies; Henriette van Praag, PhD, Florida Atlantic University; and Bruce M. Spiegelman, PhD, Dana-Farber Cancer Institute.
The study was supported with grants from the Cure Alzheimer’s Fund, the JPB Foundation, the Mather’s Foundation, The Leona and Harry Helmsley Charitable Trust, and the National Institutes of Health grants R01 MH060009, 1RF1 AG048080-01 and 2R01 AG014713.
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $900 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, genomic medicine, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2018 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of "America's Best Hospitals."
Media contact: Terri Ogan, email@example.com, 617 726-0954